TY  - GENERIC
DO  - 10.20944/preprints202410.0856.v1
UR  - http://dx.doi.org/10.20944/preprints202410.0856.v1
TI  - Preclinical Pharmacokinetics studies of SPH5030, a Novel, Selective, Potent, and Irreversible HER2 Inhibitor
T2  - Preprints
AU  - Gong, Xuelian
AU  - Xia, Guangxin
PY  - 2024
DA  - 2024/10/12
PB  - Preprints